The £2B eye drop market: what's really in your bottle?
From glaucoma to dry eye, millions of Brits rely on eye drops daily. The UK ophthalmic drugs market report by MRFR shows that anti‑inflammatory drugs are the largest segment, but antiglaucoma drugs are the fastest‑growing. The market is $2.06 billion and will hit $3.8 billion by 2035, growing at 5.73% CAGR. Why the rise? Because an aging population means more eye disease. What's...
0 Commentarios 0 Acciones 3 Views 0 Vista previa